1. Introduction {#sec1}
===============

Infectious diarrhea causes almost 500,000 deaths per year, especially among children up to five years of age from Asia, Africa, and Latin America \[[@B1], [@B2]\]. Incidence varies between countries and regions, due to a number of recognized factors, such as the socioeconomic group, nutritional status, access to safe water sources, wastewater disposal, food safety, electricity supply, refrigeration of food, and close contact with animal reservoirs of potential pathogens. Infectious diarrheal diseases are particularly prevalent in younger children from low income homes \[[@B3]--[@B5]\].

Diarrheal disease is very important due to its high morbidity and mortality. Attention must also be given to its links with malnutrition and to the high cost of medical attention that impacts an already burdened health system in many developing countries \[[@B6]\]. Severe cases and related complications often require specialized care, which includes diarrheal diseases characterized by severe dehydration (found in cholera cases), bloody diarrhea caused by *Shigella*, haemolytic-uremic syndrome (HUS) associated with infection by Shiga toxin-producing *E. coli* (STEC), Guillain--Barré Syndrome (GBS) linked to *Campylobacter,* and invasive illness by *Salmonella* or acute abdominal pain due to mesenteric adenitis and *Yersinia enterocolitica* \[[@B7], [@B8]\].

Laboratory investigation of all potential diarrheal agents presently involves complicated and expensive procedures, and it is not usually required or performed to manage individual cases \[[@B9], [@B10]\]. However, control measures to combat acute diarrheal disease of children in primary care settings cannot be adequately oriented if predisposing conditions, etiologic agents, and their epidemiologic-spread profile are not fully known and available to health care decision-makers \[[@B2], [@B5]\].

Diarrheagenic *E. coli* (DEC) is a group of strains that do not form part of the human intestinal microbiota but can be transmitted from food or infected humans to susceptible children and adults resulting in a range of disease that can be very serious and frequent. Several overlapping virulent types that are capable of gene transfer include enterotoxigenic *E. coli* (ETEC), enteropathogenic *E. coli* (EPEC), enteroaggregative *E. coli* (EAEC), Shiga-toxin-producing *E. coli* (STEC), and enteroinvasive *E. coli* (EIEC). Diffuse-adherent *E. coli* DAEC or adherent-invasive *E. coli* AIEC is also a potential member of DEC that requires further study \[[@B11], [@B12]\].

For many years, our workgroup has participated in the surveillance of acute diarrheal disease in Uruguayan children \[[@B13]--[@B16]\], and we confirmed that EPEC is the most prevalent DEC pathotype locally. Shiga toxin-producing *Escherichia coli* (STEC), mainly non-O157, EAEC, and ETEC were also identified as being present locally, and EIEC was confirmed but less frequently \[[@B13], [@B14]\].

Most Uruguayan DEC studies (and more general studies concerning diarrheal disease and pertinent agents) have been conducted in urban Montevideo \[[@B13]--[@B16]\] and have provided useful information. However, these studies need to be complemented with studies from smaller towns and rural areas where the epidemiology, spread, distribution, and characteristics of enteropathogenic microorganisms can vary \[[@B17]\].

This study deals with the etiology of acute diarrhea in children and intends to overcome the mentioned weaknesses of existing knowledge, by focusing on DEC detection in children from small towns in the interior regions of Uruguay and on characterization of isolates.

2. Materials and Methods {#sec2}
========================

The study period ran from October 2012 to March 2015.

2.1. Approvals and Consent {#sec2.1}
--------------------------

The study was approved by the Ethics Bureau of Medicine Faculty, UdelaR, and by the Mercedes Hospital Committee. An informed consent was obtained from each child´s parent, following the explanation of the study and procedures.

2.2. Sampling and Data Recording {#sec2.2}
--------------------------------

We examined stool samples (*n*=83) from children up to 5 years of age who suffered acute community diarrhea, defined as three or more discharges within 12 hours, or just one liquid or semiliquid stool including mucus, pus, or blood. The children were brought to the attention of health services of small- or medium-sized towns; most of them in Mercedes, Soriano. Children with persistent diarrhea, patients receiving antibiotics, or those who had been hospitalized within 30 days prior to the onset of diarrhea were excluded.

A single stool sample was obtained from each child through spontaneous defecation and was collected in a sterile, wide-mouth plastic container. Part of the sample was transferred with a sterile swab to a tube of semisolid Cary--Blair transport medium (C-B) (HIMEDIA®Laboratories).

Data regarding the symptoms of the disease, macroscopic stool aspect, nutritional and hydration status, therapy administered, and potential infected contacts, were collected for each patient as carefully as possible.

2.3. Microbiological Analysis of Stools {#sec2.3}
---------------------------------------

The detection of rotavirus and adenovirus antigens was performed in the Mercedes Hospital Laboratory by the immunochromatographic technique, according to the manufacturers´ instructions (RIDA Quick Norovirus and RIDA Quick Rotavirus/Adenovirus Combi-Biopharm AG, Darmstadt, Germany). Both parts of the sample (with and without C-B transport medium) were immediately sent to the Bacteriology and Virology Department, at the Institute of Hygiene. Identification of enteric pathogens was conducted there as previously described \[[@B13], [@B14]\].

Following macroscopic observation to identify abnormal components (blood, pus, or mucus), two slide smears were prepared from feces without the transport medium: one stained with methylene blue for detection and gross quantification of fecal leucocytes, and the other one stained with the modified Gram technique (Ziehl\'s fuchsin diluted 1/10 instead of Safranin as counterstain) to discover spiral forms, suggestive of *Campylobacter*.

Enrichment broths for STEC, *Salmonella, Yersinia*, and selective-differential plate media for isolation of *Salmonella, Shigella*, *Yersinia enterocolitica, Campylobacter,* and *E. coli* pathotypes were inoculated from both parts of the stool sample (with and without C-B transport medium) to optimize pathogen recovery. Dense feces were diluted in saline solution.

The enrichment broths used were Tetrathionate broth (TT) for *Salmonella,* cefixime-tellurite trypticase Soy Broth (CT-TSB) for STEC, and peptone sorbitol bile broth (PSB) for *Yersinia*. Plating media were MacConkey Lactose and Sorbitol MacConkey (SMAC), mainly employed for the isolation of DEC, *Salmonella*-*Shigella* agar (SS), and Skirrow selective medium for *Campylobacter*. *Yersinia enterocolitica* was selected on MacConkey agar or cefsulodin-irgasan-novobiocin (CIN) agar. The commercial sources for most of the culture media were Difco®, Becton-Dickinson, and Oxoid® Ltd., Basingstoke, Hampshire, UK, while Sigma-Aldrich® and bioMérieux®, Marcy l\'Etoile, France, provided added chemical or antimicrobial mixes.

One gram or 1 ml stools were inoculated in 10 ml liquid enrichment broths. Subculture from CT-TSB was performed on SMAC before 18 hours incubation, after 24 hours from TT to SS for *Salmonella* and after 21 days incubation at 4°C--8°C on MacConkey or CIN media from PSB. Incubation was kept at 35°C--37°C for most media, at 28°C for *Yersinia*, at 43°C for TT broth, and for Skirrow plates included in microaerophilic environment.

Classical phenotypic tests were employed to identify *Salmonella, Shigella, Yersinia*, and *Campylobacter*. Occasionally, it was necessary to use the API 20E system (bioMérieux®, Marcy l\'Etoile, France) or Vitek 2 and MicroScan/AutoScan® equipment for completing the identification of isolates.

2.4. Investigation of DEC Pathotypes {#sec2.4}
------------------------------------

Suspected *E. coli* colonies on MacConkey or SMAC plates were studied by PCR screening \[[@B14], [@B16], [@B18]\] following a two-step process:Firstly, gene-specific PCR assays were performed to detect DEC pathotypes ([Table 1](#tab1){ref-type="table"}) in DNA extracted from the confluent growth zone of spread plates and from several 10-colony pools taken from primary or subculture plates. The pools included sorbitol negative, sorbitol positive, and lactose-positive bacteria. Individual colonies were kept at 4°C for further studies.A confirmation step followed to amplify sequences of DNA extracted from slant cultures obtained from individual colonies of positive pools. This was not always possible, due to loss of viability of some saved colonies.

For DNA extraction, bacterial cultures suspended in Milli-Q® water and heated in boiling water for 5 minutes. After 10 min at 4°C, they were centrifuged at 13,000 rpm for 10 min, and the supernatant containing released DNA was kept at −20°C until use.

Amplifications were performed in reaction volumes of 25 *µ*L containing 0.2 mM dNTPs, 0.2 *µ*M primers (SBS Genetech Co, Ltd), 10 mM Tris-HCl, 2 mM MgCl~2~, 1.5 U Taq polymerase (HybriPol Bioline, UK), and 2.5 *µ*L crude template DNA. The thermocycler used was a GeneAmp 2700 (Applied Biosystems®, California, US).

Conditions were similar for all reactions, consisting of 94°C initial denaturation for 5 minutes, followed by 30 cycles of 1 min at 94°C followed by different annealing temperatures for 1 min and a further 1 min at 72°C. The final extension period was set at 72°C for 10 min. PCR products were visualized with ethidium bromide staining after electrophoresis in 2% agarose gels in 0.5X TBE buffer.

The first PCR screenings were performed with *stx*1/*stx*2 and *eae* primers focusing on the selection of STEC or EPEC DEC. DNA yielding positive *eae* and negative *stx*1/*stx*2 PCR results was then examined with *bfp* primers to differentiate tEPEC from aEPEC. Negative *eae* and *stx*1/*stx*2 extracts were examined with pCVD432 primers for plasmidic EAEC sequences, *ipa*H primers for detecting genes coding the invasion plasmid antigen of EIEC (and *Shigella)*, and with PCR tests for *eltA* and *estA* genes of ETEC labile and stable enterotoxins.

The primer sequences, annealing temperatures, expected sizes of PCR products, and information sources can be seen in [Table 1](#tab1){ref-type="table"} \[[@B16]--[@B22]\].

Isolates selected as presumptive DEC were biochemically tested to confirm that they belonged to the *E*. *coli* species. Serotyping and antimicrobial susceptibility assays were performed. Pathotypes were confirmed, and data were added to strains identification.

Serotypes were determined at the Universidad Nacional Autónoma de Mexico, using Ørskov and Ørskov′s agglutination assay, 96-well microtiter plates, and rabbit serum (SERUNAM) obtained against 187 somatic antigens and 53 flagellar antigens of *E*. *coli*.

The disc diffusion method was employed as recommended by Clinical Laboratory Standards Institute (CLSI standards) for determining antimicrobial susceptibility of all confirmed DEC isolates \[[@B23]\]. Employed discs (Oxoid® Ltd., Basingstoke, Hampshire, UK) contained ampicillin, cefradine, cefoxitin, cefuroxime, ceftriaxone, ceftazidime, sulbactam-ampicillin, imipenem, meropenem, ciprofloxacin, trimethoprim-sulfamethoxazole, nalidixic acid, gentamicin, and amikacin. Vitek® or MicroScan® systems were used for confirmation when required.

2.5. Data Analysis {#sec2.5}
------------------

Statistical analysis was performed by Epi-Info 2000 software developed by PAHO (Pan American Health Organization). When comparing relative frequencies, the chi-square test was used for establishing or discarding a link between qualitative variables. Fisher\'s exact test was used if sample sizes were small. A *p* value \<0.05 was regarded as statistically significant.

3. Results {#sec3}
==========

Forty female and 43 male infants (*n*=83) were studied, aged from 20 days to 5 years; the average age was 10 months.

All children showed an adequate nutritional status and hydration level upon onset of acute diarrhea. Other basic clinical data of the children with diarrhea caused by a single enteropathogen are shown in [Table 2](#tab2){ref-type="table"}. Ongoing diarrhea was watery in 24 children (28.91%), semiliquid in 28 (33.75 %), mucoid in 26 (31.32 %), and blood-stained in five (6.02 %).

Cases occurred throughout the year, with higher frequency in late spring and summer.

3.1. Number and Types of Detected Enteropathogens {#sec3.1}
-------------------------------------------------

One or more potentially pathogenic enteric agents were identified in 30 of the 83 children (36.14%).

There were 33 enteropathogens identified: DEC, 17 (20.48 %); rotavirus, 12 (14.45%); and adenovirus, 4 (4.81%). DEC distribution was as follows: aEPEC (*eae+, bfp-*, *and stx-*) in 13 children, EIEC (*ipa*H+) in 3, and STEC (*eae+, stx*2+) in one child. Neither ETEC nor EAEC sequences were detected. Three children showed coinfections: aEPEC and rotavirus in two cases and aEPEC and adenovirus in one. Viruses were found as single diarrhea-associated pathogens in 13 children and DEC in 14 cases.

Individual colonies were available for further studies in 13 of the 17 samples in which PCR yielded positive results for DEC. This could not be done with the 4 other DEC suspected plates. [Table 3](#tab3){ref-type="table"} shows the pathotypes and serotypes of recovered DEC isolates.

Recovered EIEC isolates (*n*=2) were lactose and lysine-decarboxylase positive, motile, and indol negative. API 20E identification code was the same for both (5104572).

No *Salmonella, Yersinia enterocolitica, Shigella,* or *Campylobacter* isolates were recovered. Significant presence of fecal leucocytes (++ or +++) was only observed in smears from 3 children: 2 with presumptive EIEC and one with confirmed aEPEC. Microscopic examination did not show any spiral bacteria suggestive of *Campylobacter*.

Clinical presentation of cases as related to etiology is shown in [Table 2](#tab2){ref-type="table"}. Diarrhea was more frequently liquid in children from which a pathogen could be identified (16/27 = 59.3% vs 7/53 = 13.2%). Bloody diarrhea was significantly associated with aEPEC etiology: 3 out of 5 children with bloody feces (4, 16, and 35 months old) were aEPEC positive, as compared with 10 of 78 with nonbloody diarrhea (*p* \< 0.05**)**. In those 3 cases, there was no virus coinfection.

Rotavirus-infected children presented with vomiting more frequently (46.2%) than aEPEC-positive patients (10%), as shown in [Table 2](#tab2){ref-type="table"}. This difference was not significant (*p* \> 0.05). Regarding rotavirus vaccine status, none of the children had been vaccinated at the time of entering the study.

3.2. Antimicrobial Susceptibility {#sec3.2}
---------------------------------

Most aEPEC studied strains showed some antibiotic resistance, with ampicillin, cefradine, sulbactam-ampicillin, and trimethoprim-sulfamethoxazole resistance being detected, as shown in [Table 3](#tab3){ref-type="table"}. Two strains were resistant to three mentioned compounds, and 1 to two of them. Both EIEC strains and the single STEC isolate were susceptible to all assayed antimicrobials.

4. Discussion {#sec4}
=============

The main observation in this study was that DEC, and especially aEPEC, were the most frequent pathogens found in this group of children, who lived in small towns of southern Uruguay. Rotaviruses were also frequently detected.

All recovered EPEC isolates were classified as atypical, due to the lack of *bfp* plasmidic genes as revealed by negative PCR results \[[@B24]\]. Atypical EPEC had been thought to be less virulent than tEPEC strains; however, it has not been proven that they are less pathogenic. In addition to virulence factors coded in LEE, intimin, Esp (*E. coli* secreted proteins), Tir (translocated intimin receptor), and T3SS (type 3 secretion system), they can express EAST1 (enteroaggregative heat stable toxin 1), E-hly (EHEC-enterohemolysin), Afa (afimbrial adhesin), and many others. Variants of intimin and other components are usually different between tEPEC and aEPEC subtypes, as are O and H antigens defining serotypes. aEPEC is a heterogeneous group of strains with diverse virulence profiles that may have acquired LEE through horizontal transfer or may have come from tEPEC that have lost the EAF plasmid \[[@B25]--[@B27]\]. Some strains seem to show more genetic similarity with STEC cell lines than with tEPEC. An aEPEC strain can be a STEC bacterium that has lost phages that code Shiga toxins. STEC and aEPEC have other antigenic and virulence traits in common, for which their relationships deserve attention and analysis in terms of molecular epidemiology. However, clinical isolates of aEPEC from patients in Australia and New Zealand \[[@B26]\] did not seem to derive from STEC or from tEPEC, and their study suggested that type I fimbriae or other adherence structures that are similar in function to bfp may contribute to their virulence.

Fecal leucocytes are seldom found in EPEC infections. However, more sensitive approaches may disclose intestinal inflammatory features or blood contents in diarrheal episodes associated with EPEC \[[@B28], [@B29]\]. In our study, a significant association was seen between aEPEC infection and bloody diarrhea; aEPEC were present in feces of 3 out of 5 children with bloody diarrhea, a clinical presentation causing concern for parents and health workers. Two of those three strains could be serotyped: O137 : H6, which was reported as an aEPEC isolate from children\'s feces in Denmark some years ago \[[@B30]\] and O166 : H21 serotype that was previously isolated by other workers as a STEC pathotype strain \[[@B31]\]. Our O166 : H21 isolate was obtained from a child who underwent surgery due to intestinal intussusception, a condition not easily distinguishable from HUS. This is noteworthy because STEC bacteria can lose phages-coding Shiga toxins even during laboratory subcultures and are defined as EHEC-LST \[[@B32], [@B33]\]. Complete sequencing of these and other aEPEC isolates recovered from children with bloody diarrhea may eventually disclose their genetic relation with STEC strains.

Atypical EPEC have been recovered from children\'s diarrhea in countries and population groups of middle to high socioeconomic level \[[@B34], [@B35]\]. Typical EPEC strains are still prevalent in poor regions of sub-Saharan Africa \[[@B36]\], but in other developing areas, aEPEC predominates as seen in developed countries \[[@B37]\]. In America, tEPEC (as defined through classic serogroup determination) was prevalent some decades ago, mainly in developing regions \[[@B13], [@B15], [@B38]\]. More recent surveillance work has revealed that aEPEC are more frequent than tEPEC in high-income and also in low income populations and regions \[[@B39]--[@B45]\].

In Uruguay, tEPEC and aEPEC still cocirculated 15 years ago among poor children \[[@B16]\], but aEPEC are prevalent in recent years both in children of high and low socioeconomic groups, as shown in this study and in another study performed using identical methods, that included children from high-income households \[[@B14]\].

It is important to highlight the great diversity of serotypes identified in this study that are also different from those found in the aforementioned local studies, and from aEPEC serotypes reported in other countries or regions \[[@B42], [@B46], [@B47]\]. However, most of the isolated serotypes and serogroups in this study have been reported as aEPEC or STEC present in animals or food of animal origin that are potential sources of human infection, except those from the O184 serogroup, that may represent a novel finding of diarrhea-associated *E. coli* bacteria that deserves further analysis \[[@B30], [@B31]\].

Atypical EPEC can have an animal reservoir, are adapted to human and animal hosts, and require particular attention, as well as STEC, when food-borne infection is suspected \[[@B24], [@B30], [@B48], [@B49]\].

Only one O145 STEC strain was identified. STEC isolates are not common in Uruguayan children, even in bloody diarrheal disease \[[@B50]\]. They seem to occur more frequently in children from high or middle-high socioeconomic groups and in small towns outside Montevideo \[[@B7], [@B14], [@B17], [@B51], [@B52]\]. Non-O157 STEC (O26, O145, and others) are the STEC groups usually found in our children, despite the geographical closeness with Argentina, where the O157 : H7 serotype is prevalent \[[@B53]\]. However, O157 : H7 has been found in Uruguay in a single case of HUS \[[@B17]\], in urinary tract infections of two older patients who did not develop HUS \[[@B51]\] and in multiple food samples \[[@B54]\].

It should be noted that an O96 : H19 EIEC serotype was isolated from two cases without an obvious epidemiological link; this serotype is described as being particularly virulent \[[@B55]\]. Our isolates seemed to be identical, but they require further molecular analysis and comparison with previous regional isolates and with European strains \[[@B55]--[@B58]\].

ETEC or EAEC pathotype strains were not found in this group of patients, although they were usually recognized in previous groups of children from Montevideo \[[@B13], [@B14], [@B16]\]. In general, ETEC strains are recovered from children who are hospitalized with acute diarrhea and severe dehydration and live in areas with a significant lack of basic services \[[@B59]\]. It does not seem to be the case in our current study. With regard to EAEC, we cannot rule out the participation of atypical strains that do not carry the high molecular weight plasmid (pCVD432). To establish the true role of EAEC strains in diarrheal episodes, we should have performed a screening using the HEp-2 adherence assay or a multiplex PCR targeting plasmid and chromosomal genes. To date, all our EAEC recognized isolates using pCVD432 PCR screening were lysine-decarboxylase positive, which raises doubts about their capacity to cause diarrhea \[[@B14], [@B60]\].

Antimicrobial treatment is not generally recommended for treatment of diarrheal diseases, with few exceptions. Susceptibility of enteric bacteria should be monitored because resistant genes selected in enteric pathogens or the microbiota can remain undisclosed and be transferred to highly pathogenic microorganisms.

Resistance to the antimicrobial agents was scarce in the DEC isolated in our study, as compared with that observed in previous studies focused on poor children in Montevideo \[[@B13]\]. This fact may result from a general tendency of enteric bacteria in Uruguay towards susceptibility or may simply confirm that the resistance level of bacterial pathogens recovered from towns in the interior of the country is usually lower than that found in the Capital city, where antimicrobial treatment is more widely available and prescribed, contributing to the selection of resistant variants.

Rotavirus infection was observed to be more frequent (14.45%) in the group of children reported here than in another previously studied group (5%) for which vaccination was available \[[@B14]\]. However, groups of children were also different in terms of social parameters and location. Rotavirus vaccine is effective \[[@B61]\] and has been employed in some health services in Uruguay, following WHO recommendation.

The overall proportion of positive etiologic diagnosis was lower (36.14%) in this study than that obtained in a recent similar study (51%) \[[@B14]\], and a limited variety of pathogens was identified. Despite using identical microbiological methods in both studies, delay or difficulties in the sample transport, differences between studied populations, influence of nondeclared previous antibiotic treatment, or other factors may provide additional support to explain a reduced frequency in etiologic diagnosis. However, if appropriate resources and laboratory conditions had been available, investigation of norovirus, usage of CIN for all *Yersinia* cultures, added primers for EAEC PCR, or molecular methods directly applied to feces could have identified a higher proportion and diversity of involved pathogens \[[@B11], [@B62]\].

5. Conclusions {#sec5}
==============

DEC and especially aEPEC are frequently associated with childhood diarrhea in Uruguay.

Atypical EPEC is a presently prevalent pathotype that includes strains closely related to STEC cell lines. Comparative characterization of these bacteria and their molecular relationship or evolution must be performed to provide additional information and data to help support prevention and control.

Animal reservoirs of aEPEC deserve particular attention and further research, considering the close relationship of suburban and rural population with production animals, and taking into account that production and export of food is frequently animal in origin is the main economic activity and income source for Uruguay.

Rotavirus infection is frequent in children throughout the country. Vaccination against this pathogen is an effective health measure that should be extended to all children.
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###### 

Primers employed for DEC detection.

  -----------------------------------------------------------------------------------------------------------------------------------
  Gene     Primer                       Sequence 5´-3´                 Amplicon Size (bp)   Annealing temperature (°C)   Reference
  -------- ---------------------------- ------------------------------ -------------------- ---------------------------- ------------
  *eae*    EAE 1                        GAGAATGAAATAGAAGTCGT           775                  55                           \[[@B18]\]

  EAE 2    GCGGTATCTTTCGCGTAATCGCC                                                                                       

                                                                                                                         

  *bfp*    EP1                          AATGGTGCTTGCGCTTGCTGC          324                  55                           \[[@B19]\]

  EP2      GCCGCTTTATCCAACCTGGTA                                                                                         

                                                                                                                         

  *stx*1   VT1-A                        GAAGAGTCCGTGGGATTACG           131                  55                           \[[@B20]\]

  VT1-B    AGCGATGCAGCTATTAATAA                                                                                          

                                                                                                                         

  *stx*2   VT2 a                        TTAACCACACCCCACCGGGCAGT        348                  55                           \[[@B20]\]

  VT2 b    GCTCTGGATGCATCTCTGGT                                                                                          

                                                                                                                         

  *ipa*H   EI1                          GTTCCTTGACCGCCTTTCCGATACCGTC   620                  55                           \[[@B21]\]

  EI2      GCCGGTCAGCCACCCTCTGAGAGTAC                                                                                    

                                                                                                                         

  pCDV\    EAEC1                        CTGGCGAAAGACTGTATCAT           630                  60                           \[[@B16]\]
  432                                                                                                                    

  EAEC2    CAATGTATAGAAATCCGCTGTT                                                                                        

                                                                                                                         

  *eltA*   LT-A-1                       GGCGACAGATTATACCGTGC           332                  55                           \[[@B16]\]

  LT-A-2   CCGAATTCTGTTATATATGTC                                                                                         

                                                                                                                         

  *estA*   STA-1                        ATTTTTATTTCTGTATTGTCTTT        147                  48                           \[[@B16]\]

  STA-2    GGATTACAACACAGTTCACAGCAG                                                                                      
  -----------------------------------------------------------------------------------------------------------------------------------

###### 

Clinical findings as related to etiology of diarrhea.

                        Children with single identified pathogen^1^ (*n*=27)   Children without identified pathogen^1^ (*n*=53)                            
  --------------------- ------------------------------------------------------ -------------------------------------------------- ---------- ------------- ------------
  Children with                                                                                                                                             
  Watery diarrhea       6 (60%)                                                ---                                                ---        10 (76, 9%)   7 (13.2%)
  Semiliquid diarrhea   ---                                                    ---                                                ---        ---           28 (52.8%)
  Bloody diarrhea       3 (30%)                                                1 (33.3%)                                          1 (100%)                 ---
  Mucoid stools         1 (10%)                                                2 (66.6%)                                          ---        3 (23.1%)     18 (34%)
  Abdominal pain        4 (40%)                                                2 (66.6%)                                          1 (100%)   6 (46.2%)     6 (11.3%)
  Fever                 2 (20%)                                                2 (66.6%)                                          1 (100%)   5 (35.5%)     5 (9.4%)
  Vomiting              1 (10%)                                                ---                                                ---        6 (46.2%)     7 (13.2%)
  Fecal leucocytes^3^   1 (10%)                                                2 (66.6%)                                          ---        ---           ---

^1^No child was vaccinated against rotavirus at the time of entering to the study; ^2^considering together: rotavirus in 10 children and adenovirus in 3; ^3^significant presence of fecal leucocytes (++ or +++). ---, no child showed those conditions.

###### 

Pathotypes and serotypes of recovered DEC isolates in Soriano, Uruguay.

  Sample       Serotype         Pathotype   Lactose utilization   Resistant to^*∗*^
  ------------ ---------------- ----------- --------------------- -------------------
  V4^**1**^    O166:H21         aEPEC       \+                    A
  V20^**1**^   O137:H6          aEPEC       \+                    ---
  V23          O165:H8          aEPEC       \+                    ---
  V30          O184:H8          aEPEC       \+                    A, SAM, CE
  V49          O118:H5          aEPEC       \+                    ---
  V54          O63:HNT^**2**^   aEPEC       \+                    CE
  V56          O184:H4          aEPEC       \+                    A, CE, SxT
  V61^**1**^   ONT:H−^**3**^    aEPEC       \+                    A, SxT
  V66          O127:H−          aEPEC       \+                    CE
  V74          ONT:H8^**3**^    aEPEC       \+                    CE
  V18^**1**^   O145:H−          STEC        \+                    A
  V48          O96:H19          EIEC        \+                    ---
  V73^**1**^   O96:H19          EIEC        \+                    ---

^*∗*^A, ampicillin; CE, cefradine; SAM, sulbactam-ampicillin; SxT, trimethoprim-sulfamethoxazole; ---, no resistance traits. ^**1**^Isolates recovered from children with bloody diarrhea. ^**2**^HNT, H-nontypable; ^**3**^ONT, O-nontypable.

[^1]: Academic Editor: Cinzia Marianelli
